ewer treatment modality for chalazion a benign lid swelling
Phase 3
- Conditions
- Health Condition 1: H001- Chalazion
- Registration Number
- CTRI/2022/06/043117
- Lead Sponsor
- Sadguru Netra Chikitsalya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patient presenting with primary chalazion
Exclusion Criteria
pregnant females and patient recieved any previous treatment for chalazion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy of 5-FU- % of reduction in size of chalazion and comparison with injection TA/I&CTimepoint: one month
- Secondary Outcome Measures
Name Time Method Complications of all 3 and its comparison <br/ ><br>Timepoint: One month <br/ ><br>